Scientists are investigating a new strain of SARS-CoV-2 that has infected over 1,000 people in South England, posing a risk to undergoing vaccine distribution.
The focus of the study by Alagappa University and KTH Royal Institute of Technology was to find drugs that can target vital proteins of the novel Coronavirus.